Aligning Regulation and HTA Earlier

João L. Carapinha, Ph.D.

Table of Contents

Poll 26 – 2026

4
Aligning Regulation and HTA Earlier

I’ve been thinking about how the growing overlap between regulatory review and HTA is changing evidence planning, pricing strategy, and reimbursement timelines in Europe. If this interface is becoming more important, what should be the top priority for improving market access? Share your insights by voting below!

 

What should be the top priority in strengthening the HTA-regulatory interface?

Table of Contents